Outsourcing in Clinical Trials West Coast 2017February 22-23 2017, Burlingame, CA
The flagship Outsourcing in Clinical Trials event on the West Coast returns to Burlingame on February 22-23 2017. The must-attend event will bring together over 700 clinical professionals from the Bay Area and beyond, to discuss clinical outsourcing strategies and overcome key challenges within clinical operations.
An interactive and case-study led agenda will see senior level executives from the pharmaceutical, biotech and medical device sectors come together to develop solutions to obstacles in their studies and optimize their operational processes.
Alongside a jam-packed programme with senior level speakers from Genentech, Raptor, Astex, Gilead, Exelixis and FibroGen to name a few; the event boasts an extensive exhibition area to provide a unique platform for networking between trial sponsors and vendors to boost partnerships and allow for in-depth knowledge sharing.
Please get in touch if you would be interested in taking part!
On top of our case-study driven agenda, the 2017 event will include interactive panel discussions providing attendees with a platform to hear from experts on their perspectives on key topics.
‘By failing to prepare, you are preparing to fail’ rings very true when considering clinical studies. Successfully preparing for study start up and taking all aspect into account is sure to improve success of your trial and should help to avoid any pitfalls further down the road.
Our world-renowned conference has built a reputation as must-attend event for pharmaceutical, medical device and biotech companies across the area. Find out here what some of our past attendees had to say.
Primary delegates for this event are those with responsibility for clinical operations, outsourcing, procurement and alliances in biotech and pharmaceutical companies in the Bay Area.
February 2017 saw biopharmaceutical and device professionals come together in San Mateo, CA for the 8th annual Outsourcing in Clinical Trials West Coast conference.